Breo Ellipta combines an inhaled corticosteroid (ICS) medicine, fluticasone furoate, and a LABA medicine, vilanterol.
FDA Approves Breo Ellipta to Treat Chronic Obstructive Pulmonary Disease (COPD).
Breo Ellipta combines an inhaled corticosteroid (ICS) medicine, fluticasone furoate, and a LABA medicine, vilanterol.
FDA Approves Breo Ellipta to Treat Chronic Obstructive Pulmonary Disease (COPD).